Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03765567 · ClinicalTrials.gov registry record · Phase 4
Placement of Antibiotic Powder in Wounds During the Emergency Room
A Phase 4 study of Open Fracture, sponsored by The University of Texas Health Science Center at San Antonio.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 200
- Enrollment target
- 2
- Study locations
NCT03765567: Recruiting Phase 4 study of Open Fracture, sponsored by The University of Texas Health Science Center at San Antonio.
NCT03765567 is a Phase 4 study of Open Fracture that is actively recruiting participants, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 200 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (61% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03765567, a Phase 4 study of Open Fracture, is actively recruiting participants, sponsored by The University of Texas Health Science Center at San Antonio.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 200 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is the first prospective controlled study to determine whether the topical application of vancomycin powder reduces infection-related complications when applied to open fracture injuries in the acute emergency department setting.
Primary Outcome
The percentage of participants who develop an infection of the study open fracture requiring post-operative surgical intervention within one year of injury.
Conditions Studied
Interventions
- DRUG Vancomycin
Study Locations (2)
Texas
- University Hospital - San Antonio
- San Antonio Military Medical Center - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2020-10-05 |
| Est. Completion | 2027-07 |
| Phase | Phase 4 |
What NCT03765567 shows while recruiting
NCT03765567 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (61% lower).
The record links to 1 condition, with Open Fracture appearing as the primary indexed condition, and to 1 intervention - of which Vancomycin is the first listed.
NCT03765567 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03765567 about?
NCT03765567 is a clinical study titled "Placement of Antibiotic Powder in Wounds During the Emergency Room". This is the first prospective controlled study to determine whether the topical application of vancomycin powder reduces infection-related complications when applied to open fracture injuries in the acute emergency department setting.
What is the current status of trial NCT03765567?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 200 participants. The study started on 2020-10-05. Estimated completion is 2027-07.
What conditions does trial NCT03765567 study?
This clinical trial studies the following conditions: Open Fracture.
What interventions are being tested in trial NCT03765567?
The interventions under investigation include: Vancomycin (DRUG).
Who is sponsoring clinical trial NCT03765567?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03765567 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Open Fracture
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03765567's enrollment target sits among peer trials
200 407th of 2000 higher than 1,557 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI